CN107969695A - A kind of spirulina tablet and preparation method thereof - Google Patents
A kind of spirulina tablet and preparation method thereof Download PDFInfo
- Publication number
- CN107969695A CN107969695A CN201711376007.3A CN201711376007A CN107969695A CN 107969695 A CN107969695 A CN 107969695A CN 201711376007 A CN201711376007 A CN 201711376007A CN 107969695 A CN107969695 A CN 107969695A
- Authority
- CN
- China
- Prior art keywords
- powder
- spirulina
- mesh
- malt
- corn flour
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 240000002900 Arthrospira platensis Species 0.000 title claims abstract description 78
- 235000016425 Arthrospira platensis Nutrition 0.000 title claims abstract description 78
- 229940082787 spirulina Drugs 0.000 title claims abstract description 78
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- 239000000843 powder Substances 0.000 claims abstract description 67
- 241000345998 Calamus manan Species 0.000 claims abstract description 27
- 239000002245 particle Substances 0.000 claims abstract description 27
- 235000012950 rattan cane Nutrition 0.000 claims abstract description 27
- 235000021324 borage oil Nutrition 0.000 claims abstract description 22
- 239000000203 mixture Substances 0.000 claims abstract description 22
- 240000008042 Zea mays Species 0.000 claims abstract description 21
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims abstract description 21
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims abstract description 21
- KZNIFHPLKGYRTM-UHFFFAOYSA-N apigenin Chemical compound C1=CC(O)=CC=C1C1=CC(=O)C2=C(O)C=C(O)C=C2O1 KZNIFHPLKGYRTM-UHFFFAOYSA-N 0.000 claims abstract description 21
- 235000005822 corn Nutrition 0.000 claims abstract description 21
- 238000003756 stirring Methods 0.000 claims abstract description 21
- 235000013312 flour Nutrition 0.000 claims abstract description 20
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims abstract description 16
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 claims abstract description 16
- 239000000661 sodium alginate Substances 0.000 claims abstract description 16
- 235000010413 sodium alginate Nutrition 0.000 claims abstract description 16
- 229940005550 sodium alginate Drugs 0.000 claims abstract description 16
- 238000001238 wet grinding Methods 0.000 claims abstract description 15
- 239000000845 maltitol Substances 0.000 claims abstract description 13
- 235000010449 maltitol Nutrition 0.000 claims abstract description 13
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 claims abstract description 13
- 229940035436 maltitol Drugs 0.000 claims abstract description 13
- 229930091371 Fructose Natural products 0.000 claims abstract description 12
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims abstract description 12
- 150000001875 compounds Chemical class 0.000 claims abstract description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 12
- 239000005715 Fructose Substances 0.000 claims abstract description 11
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims abstract description 11
- 239000012153 distilled water Substances 0.000 claims abstract description 9
- 238000001035 drying Methods 0.000 claims abstract description 9
- 238000000465 moulding Methods 0.000 claims abstract description 6
- 235000020985 whole grains Nutrition 0.000 claims abstract description 6
- 238000002156 mixing Methods 0.000 claims abstract description 3
- 241001072256 Boraginaceae Species 0.000 claims description 7
- 235000007689 Borago officinalis Nutrition 0.000 claims description 7
- 241000195493 Cryptophyta Species 0.000 claims description 6
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 5
- 239000011734 sodium Substances 0.000 claims description 5
- 229910052708 sodium Inorganic materials 0.000 claims description 5
- 239000007921 spray Substances 0.000 claims description 5
- 235000013399 edible fruits Nutrition 0.000 claims description 3
- 238000007873 sieving Methods 0.000 claims description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 2
- 229920003063 hydroxymethyl cellulose Polymers 0.000 claims 2
- 229940031574 hydroxymethyl cellulose Drugs 0.000 claims 2
- 238000005469 granulation Methods 0.000 claims 1
- 230000003179 granulation Effects 0.000 claims 1
- 150000005846 sugar alcohols Chemical class 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 4
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- 238000012216 screening Methods 0.000 abstract 1
- 239000003826 tablet Substances 0.000 description 25
- 230000000694 effects Effects 0.000 description 17
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 12
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 11
- 235000020664 gamma-linolenic acid Nutrition 0.000 description 11
- 229930003231 vitamin Natural products 0.000 description 9
- 235000013343 vitamin Nutrition 0.000 description 9
- 239000011782 vitamin Substances 0.000 description 9
- 229940088594 vitamin Drugs 0.000 description 9
- 150000003722 vitamin derivatives Chemical class 0.000 description 9
- 229960002737 fructose Drugs 0.000 description 7
- 230000008821 health effect Effects 0.000 description 7
- 235000019359 magnesium stearate Nutrition 0.000 description 6
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 206010011224 Cough Diseases 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- 230000000144 pharmacologic effect Effects 0.000 description 4
- 230000002265 prevention Effects 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 3
- -1 carrotene Chemical class 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229930003944 flavone Natural products 0.000 description 3
- 235000011949 flavones Nutrition 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 235000009388 Parthenocissus quinquefolia Nutrition 0.000 description 2
- 241000219099 Parthenocissus quinquefolia Species 0.000 description 2
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000000172 allergic effect Effects 0.000 description 2
- 238000005267 amalgamation Methods 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000003628 erosive effect Effects 0.000 description 2
- 150000002213 flavones Chemical class 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 description 2
- 229960002733 gamolenic acid Drugs 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 230000000050 nutritive effect Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 2
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 2
- 239000012258 stirred mixture Substances 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 102000015779 HDL Lipoproteins Human genes 0.000 description 1
- 108010010234 HDL Lipoproteins Proteins 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- 102000007330 LDL Lipoproteins Human genes 0.000 description 1
- 108010007622 LDL Lipoproteins Proteins 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 206010028116 Mucosal inflammation Diseases 0.000 description 1
- 201000010927 Mucositis Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010033372 Pain and discomfort Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000035567 cellular accumulation Effects 0.000 description 1
- 230000004700 cellular uptake Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 125000005481 linolenic acid group Chemical group 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 210000003739 neck Anatomy 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 238000005453 pelletization Methods 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 230000005195 poor health Effects 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000004554 water soluble tablet Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L17/00—Food-from-the-sea products; Fish products; Fish meal; Fish-egg substitutes; Preparation or treatment thereof
- A23L17/60—Edible seaweed
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/20—Agglomerating; Granulating; Tabletting
- A23P10/28—Tabletting; Making food bars by compression of a dry powdered mixture
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention discloses a kind of spirulina tablet and preparation method thereof, including：Spirulina powder, long-lived rattan powder, corn flour, chamomile powder, fructose, maltitol, malt Hu essence, borage oil, sodium cellulose glycolate and sodium alginate；It is further comprising the steps of：Spirulina powder, long-lived rattan powder and corn flour mixing are taken, stirring, forms powder mixture；Powder mixture is screened with sieve；Powder mixture after screening is sprayed into distilled water, stirs 5min；Chamomile powder, fructose, maltitol, malt essence and borage oil recklessly are added, stirs 10min, drying, forms wet-milling particle；Wet-milling particle is added into sodium cellulose glycolate and sodium alginate, stirs 30min；Whole grain, forms compound particles；Compound particles are sieved, molding is in blocks, forms spirulina tablet.By the above-mentioned means, the present invention has the characteristics that technique is simple, active component content is high, product quality is stable, good mouthfeel, it is more suitable for industrialized production.
Description
Technical field
The present invention relates to spirulina health-care tablet field, more particularly to a kind of spirulina tablet and preparation method thereof.
Background technology
There is abundant nutritive value in spirulina：Carbohydrate content is moderate, and species is enriched；Protein content is high,
Amino acid composition is reasonable；Unrighted acid accounting is high, contains a small amount of GLA (g- leukotrienes, Gamma-Linolenic
Acid, abbreviation GLA)；Content of mineral substances is comprehensive, and vitamin content enriches.The distinctive health-care effect of spirulina and bioactivity are
It is subjected to extensive concern and the utilization of biology, nutrition and medical field.Based on the research to spirulina breeding and algae powder
Time is more early, and China has become the big producer of world wide inside spin algae powder at present.
However, spirulina powder has not pleasant mouthfeel and is stained with stickiness in itself, it is quite inconvenient to take.For side
Just consumer preferably takes spirulina, and most of enterprise is all that spirulina powder is made tablet as production marketing.
General spirulina tablet is all original flavor, and mouthfeel is not good enough；And general spirulina tablet is made using magnesium stearate
For thickening and antiplastering aid, there is special smell since magnesium stearate itself is micro- and do not allow degradable side effect of Denging, so reducing spirulina
The mouthfeel and health of tablet, cause part population with rear uncomfortable, or even long-term consumption has the risk of calculus.
In addition, spirulina contains substantial amounts of liposoluble vitamin, such as carrotene, simple water-soluble tablets are easily made
Into the shortcomings that absorption and conversion performance is bad, and spirulina utilization rate is not high；
Spirulina powder antibacterial action itself is weaker, apt to deteriorate；
Spirulina contains the materials such as substantial amounts of protein, vitamin and unrighted acid, body can be carried out effective
Cleaning and adjustment effect, still, while it can also bring the symptoms such as certain stomachache, diarrhea, it is necessary to auxiliary for person in poor health
Material is helped to relax the adjustment effect of spirulina, strengthens adaptive faculty of the crowd to spirulina health-care medicine, while improve the more of tablet
The performance of kind comprehensive health-care, but spiral algae sheet currently on the market is substantially the higher original flavor tablet of purity, it is impossible to meet
Demand of the market to health medicine functional diversities.
The content of the invention
The invention mainly solves the technical problem of providing a kind of spirulina tablet and preparation method thereof, passes through long-lived rattan powder
Addition can strengthen health properties and effectively inhibit bacteria erosion, can also relax spirulina regulation performance at the same time adjuvant
Piece plays more preferable health-care effect；Can be effectively anti-stick by the setting of corn flour；By the addition of chamomile powder, can improve
The mouthfeel and smell of tablet；By the addition of borage oil, improve the linolenic contents of g- and strengthen fat-soluble dimension in spirulina
The absorbability of raw element.
In order to solve the above technical problems, the present invention provides a kind of spirulina tablet, including following component：30-40wt%'s
Spirulina powder；The long-lived rattan powder of 23-28wt%；The corn flour of 10-15wt%；The chamomile powder of 3-5wt%；The fruit of 2-5wt%
Sugar；The maltitol of 3-6wt%；The malt of 10-15wt% is recklessly smart；The borage oil of 2-4wt%；The sodium alginate of 1-2wt%；
The sodium cellulose glycolate of 1-2wt%, total amount 100%；
The spirulina tablet is made of following steps：
(a), mix：Spirulina powder, long-lived rattan powder and corn flour mixing are taken, stirring, forms powder mixture；
(b), screen：Powder mixture made from step (a) is screened with sieve, the mesh number scope of the sieve is 100-
150 mesh；
(c), pelletize：Powder mixture after step (b) is screened sprays distilled water, stirs 5min；Addition chamomile powder,
Essence and borage are oily recklessly for fructose, maltitol, malt, stir 10min, drying, forms wet-milling particle；Wet-milling particle is added into hydroxyl
Sodium carboxymethylcellulose pyce and sodium alginate, stir 30min；Whole grain, forms compound particles；
(d), tabletting：Compound particles molding is in blocks, form spirulina tablet.
Further, spirulina tablet includes following component：The spirulina powder of 35wt%；The long-lived rattan powder of 25wt%；
The corn flour of 10wt%；The chamomile powder of 4wt%；The fructose of 4wt%；The maltitol of 5wt%；The malt of 12wt% is recklessly smart；
The borage oil of 2wt%；The sodium alginate of 1.5wt%；The sodium cellulose glycolate of 1.5wt%.
Further, the granularity of the spirulina powder is 150 mesh, and the granularity of the longevity rattan powder is 150 mesh, the corn
The granularity of powder is 150 mesh, and the granularity of the chamomile powder is 100 mesh.
A kind of preparation method of spirulina tablet of the present invention, comprises the following steps：
Feeding：Take out spirulina powder, long-lived rattan powder, the corn flour of 10-15wt%, the 3- of 23-28wt% of 30-40wt%
The chamomile powder of 5wt%, the fructose of 2-5wt%, the maltitol of 3-6wt%, the malt of 10-15wt% are recklessly smart, 2-4wt%
The sodium cellulose glycolate of borage oil, the sodium alginate of 1-2wt% and 1-2wt%, total amount 100% are spare；
(a), mix：The spirulina powder got ready, long-lived rattan powder and corn flour are mixed, dry powder is formed after being sufficiently stirred
Mixture；
(b), screen：Powder mixture made from step (a) is screened with sieve, the mesh number scope of the sieve is 150
Mesh；
(c), pelletize：Powder mixture after step (b) is screened sprays distilled water, stirs 5min；Addition chamomile powder,
Essence and borage are oily recklessly for fructose, maltitol, malt, stir 10min, drying, forms wet-milling particle；Wet-milling particle is added into hydroxyl
Sodium carboxymethylcellulose pyce and sodium alginate, stir 30min；Whole grain, forms compound particles；
D), tabletting, compound particles are sieved, and molding is in blocks, form spirulina tablet.
Further, the pelletization of the step (c), the dosage of the distilled water of sprinkling is 18wt%, drying temperature
Spend for 60 degrees Celsius, time 30min.
Further, the water content of the wet-milling particle is 10wt%.
Further, in the tableting processes of the step (d), the mesh number of the sieving is 40 mesh.
The beneficial effects of the invention are as follows：The addition that a kind of spirulina tablet of the present invention and preparation method thereof passes through long-lived rattan powder
Health properties can be strengthened and effectively inhibit bacteria erosion, the regulation performance that can also relax spirulina aids in tablet to play at the same time
More preferable health-care effect；Can be effectively anti-stick by the setting of corn flour；Pass through the addition of chamomile powder, moreover it is possible to strengthen certain
Health properties and mouthfeel；By the addition of borage oil, improve the linolenic contents of g- and strengthen fat-soluble dimension life in spirulina
The absorbability of element, while be combined with the vitamin in spirulina, strengthen both amalgamations, and then strengthen pharmacological property.
Embodiment
The technical solution in the embodiment of the present invention will be clearly and completely described below, it is clear that described implementation
Example is only the part of the embodiment of the present invention, instead of all the embodiments.Based on the embodiments of the present invention, this area is common
All other embodiment that technical staff is obtained without making creative work, belongs to the model that the present invention protects
Enclose.
The embodiment of the present invention includes：
A kind of spirulina tablet, including following component：
The spirulina powder of 35wt%；
The long-lived rattan powder of 25wt%；
The corn flour of 10wt%；
The chamomile powder of 4wt%；
The fructose of 4wt%；
The maltitol of 5wt%；
The malt of 12wt% is recklessly smart；
The borage oil of 2wt%；
The sodium alginate of 1.5wt%；
The sodium cellulose glycolate of 1.5wt%.
The granularity of the spirulina powder is 150 mesh.
The granularity of the longevity rattan powder is 150 mesh.
The granularity of the corn flour is 150 mesh, and the granularity of the chamomile powder is 100 mesh.
Above-mentioned spirulina tablet is prepared by following steps：
Feeding：Take out the spirulina powder of 35wt%, the long-lived rattan powder of 25wt%, the corn flour of 10wt%, 4wt% it is foreign sweet
Inulin, the fructose of 4wt%, the maltose of 5wt%, the malt of 12wt% are recklessly smart, 2wt% borage is oily, the seaweed of 1.5wt%
The sodium cellulose glycolate of sour sodium and 1.5wt%, total amount 100% are spare；
(a), mix：The spirulina powder got ready, long-lived rattan powder and corn flour are mixed, dry powder is formed after being sufficiently stirred
Mixture；
(b), screen：Powder mixture made from step (a) is screened with sieve, the mesh number scope of the sieve is 150
Mesh；
(c), pelletize：Powder mixture after step (b) is screened sprays distilled water, the dosage of the distilled water of sprinkling
For 18wt%, drying temperature is 60 degrees Celsius, time 30min, after water is sprayed, stirs 5min；Add chamomile powder, fruit
Sugar, maltitol, malt recklessly essence and borage oil, stir 10min, drying, formed wet-milling particle, the wet-milling particle it is aqueous
Measure as 10wt%；Wet-milling particle is added into sodium cellulose glycolate and sodium alginate, stirs 30min；Whole grain, forms compound particles
Grain；
D), tabletting, compound particles are sieved, and the mesh number of the sieving is 40 mesh, and molding is in blocks, form spiral algae sheet
Agent.
In the present invention, the longevity rattan powder, using at least one of the root, stem or leaf of wild vine tea raw material fine gtinding
Form；
Clinical test proves, its contained chromocor compound of wild vine tea have clearing heat and detoxicating, expelling phlegm and arresting coughing, antibacterial anti-inflammatory,
Ease pain detumescence, blood fat-reducing blood pressure-decreasing, prevention cardiovascular and cerebrovascular disease, moreover it is possible to suppress abnormal capillary, removing free radical, it is antitumor and
The multiple efficacies such as improve the immunity of the human body.
Long-lived rattan flavones content highest in current all plants being found, can effectively prevent cardiovascular and cerebrovascular disease；It is long
Longevity rattan has trophism, pharmacological rich in 14 kinds of trace elements such as 17 kinds of amino acid and potassium, calcium, iron, zinc, selenium,
Flavones contained by long-lived rattan can sterilize anti-inflammatory, it is clearing heat and detoxicating, analgesia detumescence, blood fat-reducing blood pressure-decreasing, the cough-relieving that wets one's whistle, adjusting carry
High body immunity, has Staphylococcus aureus, first, beta streptococcus, Diplococcus pneumopniae, Bacillus influenzae etc. very strong killing energy
Power.
Long-lived rattan is nontoxic, and property is gentle, has no toxic side effect, and Chinese and Western medicine can be aided in play more preferable effect；
Since flavone compound can improve the absorption rate of protein, pass through long-lived rattan powder and spirulina powder
Collocation uses, can be balanced nutritious, improves health properties, moreover it is possible to improve the absorption rate of protein in spirulina, reinforcing sheet
The performance of agent.
In the present invention, borage oil is refined by borage and obtained, and borage is once applied to prevention pyreticosis and pneumonia；By
In it with saliferous component, the activity of kidney can be promoted, therefore be used to treat Acute mucositis.It can extract as moderator
Mucus is comprised in whole plant；It is normally used as one kind and spreads on the lenitive plaster in injury；Borage oil can be controlled
The release of lymphokine processed, reduces the propagation of immunocyte, in case (this situation substantially occurs in autologous other cells in human body
Immune disease, as rheumatic arthritis) also lower histamine secretion, help prevent extensive allergic reaction；
Wherein, (g- leukotrienes, Gamma-Linolenic Acid, the letter of the GLA in the borage oil containing 20-26%
Claim GLA), it is that the content of material is highest in nature；The spirulina of 5-10g could obtain borage oil phase with 500mg etc.
The GLA of deal；
Contain vitamin E in spirulina, can preferably be merged with borage oil, it is complementary beneficial to realizing；
Contain substantial amounts of liposoluble vitamin, such as carrotene in spirulina, pass through the addition of borage oil, Ke Yizeng
The dissolving of vitamin and absorbent properties, improve both resource utilizations in strong spirulina；
Therefore borage oil is used with spirulina powder collocation, can be had by the complementation of mutual vitamin and GLA
The nutritive value and health value of effect ground enhancing spirulina.
Wherein, the activity of GLA is more than ten times higher than other linolenic acids, is widely used in treatment gastro-intestinal problems, asthma, cough
Cough, in the healing of wound and gynaecological disease, reduce the pain and discomfort of women physiological period；GLA also has the work(for reducing T-CHOL
Can, while also have the function that to increase high-density lipoprotein, thus can also suppress cellular uptake and accumulation low-density lipoprotein courage
Sterol, can more exclude to have accumulated cholesterol in the cell, have significant effect in terms of triglyceride, cholesterol is reduced；GLA
Can also blood pressure lowering, reducing blood lipid, prevention of arterial hardening, and the prevention of cancer.
In the present invention, magnesium stearate is replaced using nontoxic sodium alginate and sodium cellulose glycolate combination, can be improved
Mouthfeel, moreover it is possible to exempt the side effect that magnesium stearate is brought.
A kind of beneficial effect of spirulina tablet of the present invention and preparation method thereof is：
First, health properties can be strengthened by the addition of long-lived rattan powder, antibiotic and sterilizing performance can be increased, can also relaxed
The regulation performance of spirulina, at the same can also auxiliary screw algae play more preferable health-care effect, improve the absorption of the resources such as protein
Utilization rate；
2nd, can be effectively anti-stick by the setting of corn flour, by the addition of chamomile powder, the mouthfeel of tablet can be improved
And smell, while certain health properties can also be strengthened；
3rd, by the addition of borage oil, the linolenic contents of g- is improved and strengthen liposoluble vitamin in spirulina
Absorbability, while be combined with the vitamin in spirulina, strengthen both amalgamations, and then strengthen pharmacological property；Borage oil is also
Body immunity can be strengthened, prevent the generation of allergic symptom；
4th, the dimension E in borage oil and spirulina is combined, and strengthens both fusions, and then strengthen pharmacological property, moreover it is possible to strengthen
Body immunity, prevents the generation of allergic symptom；
5th, mouthfeel can be improved by the addition of chamomile powder, strengthens the adaptability of taste, moreover it is possible to strengthen what is clear liver and improved vision
Health-care effect；
6th, magnesium stearate is replaced by sodium alginate and sodium cellulose glycolate combination, mouthfeel can be improved, moreover it is possible to exempt
The side effect that magnesium stearate is brought；
7th, it is simple with technique compared with common spirulina tablet, easy to process, health properties variation, tablet
Utilization rate higher, spirulina more relax the adjustment effect of body and act on the advantages that more rich and varied, are adapted to market pair
The demand of health product multifunction, is also suitable for the demand of industrialized production.
The foregoing is merely the embodiment of the present invention, is not intended to limit the scope of the invention, every to utilize this hair
The equivalent structure or equivalent flow shift that bright description is made, is directly or indirectly used in other relevant technology necks
Domain, is included within the scope of the present invention.
Claims (7)
1. a kind of spirulina tablet, it is characterised in that including following component：The spirulina powder of 30-40wt%；23-28wt%'s
Long-lived rattan powder；The corn flour of 10-15wt%；The chamomile powder of 3-5wt%；The fructose of 2-5wt%；The maltitol of 3-6wt%；
The malt of 10-15wt% is recklessly smart；The borage oil of 2-4wt%；The sodium alginate of 1-2wt%；The hydroxymethyl cellulose of 1-2wt%
Sodium, total amount 100%；
The spirulina tablet is made of following steps：
(a), mix：Spirulina powder, long-lived rattan powder and corn flour mixing are taken, stirring, forms powder mixture；
(b), screen：Powder mixture made from step (a) is screened with sieve, the mesh number scope of the sieve is 100-150
Mesh；
(c), pelletize：Powder mixture after step (b) is screened sprays distilled water, stirs 5min；Add chamomile powder, fruit
Essence and borage are oily recklessly for sugar, maltitol, malt, stir 10min, drying, forms wet-milling particle；Wet-milling particle is added into hydroxyl first
Base sodium cellulosate and sodium alginate, stir 30min；Whole grain, forms compound particles；
(d), tabletting：Compound particles molding is in blocks, form spirulina tablet.
2. a kind of spirulina tablet according to claim 1, it is characterised in that including following component：35wt%'s is spiral
Algae powder；The long-lived rattan powder of 25wt%；The corn flour of 10wt%；The chamomile powder of 4wt%；The fructose of 4wt%；The malt of 5wt%
Sugar alcohol；The malt of 12wt% is recklessly smart；The borage oil of 2wt%；The sodium alginate of 1.5wt%；The hydroxymethyl cellulose of 1.5wt%
Sodium.
A kind of 3. spirulina tablet according to claim 1, it is characterised in that the granularity of the spirulina powder is 150 mesh,
The granularity of the longevity rattan powder is 150 mesh, and the granularity of the corn flour is 150 mesh, and the granularity of the chamomile powder is 100 mesh.
4. a kind of preparation method of spirulina tablet, it is characterised in that comprise the following steps：
Feeding：Take out spirulina powder, long-lived rattan powder, the corn flour of 10-15wt%, the 3- of 23-28wt% of 30-40wt%
The chamomile powder of 5wt%, the fructose of 2-5wt%, the maltitol of 3-6wt%, the malt of 10-15wt% are recklessly smart, 2-4wt%
The sodium cellulose glycolate of borage oil, the sodium alginate of 1-2wt% and 1-2wt%, total amount 100% are spare；
(a), mix：The spirulina powder got ready, long-lived rattan powder and corn flour are mixed, dry powder blend is formed after being sufficiently stirred
Thing；
(b), screen：Powder mixture made from step (a) is screened with sieve, the mesh number scope of the sieve is 150 mesh；
(c), pelletize：Powder mixture after step (b) is screened sprays distilled water, stirs 5min；Add chamomile powder, fruit
Essence and borage are oily recklessly for sugar, maltitol, malt, stir 10min, drying, forms wet-milling particle；Wet-milling particle is added into hydroxyl first
Base sodium cellulosate and sodium alginate, stir 30min；Whole grain, forms compound particles；
D), tabletting, compound particles are sieved, and molding is in blocks, form spirulina tablet.
5. the preparation method of spirulina tablet according to claim 4, it is characterised in that the granulation of the step (c)
Journey, the dosage of the distilled water of sprinkling is 18wt%, and drying temperature is 60 degrees Celsius, time 30min.
6. the preparation method of spirulina tablet according to claim 5, it is characterised in that the water content of the wet-milling particle
For 10wt%.
7. the preparation method of spirulina tablet according to claim 5, it is characterised in that the tabletting of the step (d)
Cheng Zhong, the mesh number of the sieving is 40 mesh.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711376007.3A CN107969695A (en) | 2017-12-19 | 2017-12-19 | A kind of spirulina tablet and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711376007.3A CN107969695A (en) | 2017-12-19 | 2017-12-19 | A kind of spirulina tablet and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107969695A true CN107969695A (en) | 2018-05-01 |
Family
ID=62006735
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201711376007.3A Pending CN107969695A (en) | 2017-12-19 | 2017-12-19 | A kind of spirulina tablet and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107969695A (en) |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1153665A (en) * | 1996-11-29 | 1997-07-09 | 罗兆文 | Spirulina mixture health product and its prepn process |
| CN1308964A (en) * | 2000-11-19 | 2001-08-22 | 广东梅县梅雁蓝藻有限公司 | Process for preparing spirulina tablet |
| CN1836689A (en) * | 2005-12-02 | 2006-09-27 | 甘肃凯源生物技术开发中心 | Tablet containing F.tataricum and spirulina spp. , and its preparation method |
| CN103169108A (en) * | 2013-04-12 | 2013-06-26 | 寿光富康制药有限公司 | Direct tablet compressing method for spirulina powder |
| CN104247771A (en) * | 2013-06-25 | 2014-12-31 | 刘铭华 | Spirulina milk tablet |
| CN104432094A (en) * | 2014-11-29 | 2015-03-25 | 黄南概 | Spirulina-mulberry health buccal tablets and preparation method thereof |
| CN104998065A (en) * | 2015-08-14 | 2015-10-28 | 哈尔滨华藻生物科技开发有限公司 | Spirulina beauty maintaining and young keeping tablet and preparation method thereof |
| CN107198007A (en) * | 2017-05-23 | 2017-09-26 | 西安天丰生物科技有限公司 | One kind is refreshed oneself antifatigue pressed candy and preparation method thereof |
-
2017
- 2017-12-19 CN CN201711376007.3A patent/CN107969695A/en active Pending
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1153665A (en) * | 1996-11-29 | 1997-07-09 | 罗兆文 | Spirulina mixture health product and its prepn process |
| CN1308964A (en) * | 2000-11-19 | 2001-08-22 | 广东梅县梅雁蓝藻有限公司 | Process for preparing spirulina tablet |
| CN1836689A (en) * | 2005-12-02 | 2006-09-27 | 甘肃凯源生物技术开发中心 | Tablet containing F.tataricum and spirulina spp. , and its preparation method |
| CN103169108A (en) * | 2013-04-12 | 2013-06-26 | 寿光富康制药有限公司 | Direct tablet compressing method for spirulina powder |
| CN104247771A (en) * | 2013-06-25 | 2014-12-31 | 刘铭华 | Spirulina milk tablet |
| CN104432094A (en) * | 2014-11-29 | 2015-03-25 | 黄南概 | Spirulina-mulberry health buccal tablets and preparation method thereof |
| CN104998065A (en) * | 2015-08-14 | 2015-10-28 | 哈尔滨华藻生物科技开发有限公司 | Spirulina beauty maintaining and young keeping tablet and preparation method thereof |
| CN107198007A (en) * | 2017-05-23 | 2017-09-26 | 西安天丰生物科技有限公司 | One kind is refreshed oneself antifatigue pressed candy and preparation method thereof |
Non-Patent Citations (4)
| Title |
|---|
| 刘殿阁等: "《临床实用医学 下册》", 30 June 2009, 黑龙江科学技术出版社 * |
| 谢麟等: "《兽用药剂技术手册》", 31 October 1993, 广西科学技术文献 * |
| 郭建生等: "《实用临床中药手册》", 31 August 2016, 湖南科学技术出版社 * |
| 陈功锡等: "《湘西药用植物资源开发与可持续利用》", 31 May 2015, 西南交通大学出版社 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100401925C (en) | Making method of health-care beverage for efficient preventing and treating asthma | |
| CN103734474B (en) | Beautifying health-care tea and preparation method thereof | |
| CN101297666B (en) | Fig leaf sweet tea and manufacturing method | |
| CN102860519A (en) | Preparation method for reducing hardness of dietary fiber chewable tablets | |
| CN104207252A (en) | Olive drink and preparation method thereof | |
| CN103652692B (en) | Radish leaf nutritional chewable tablet and preparation method | |
| KR101051519B1 (en) | Method for manufacturing ginseng-berry extract | |
| CN110313530A (en) | A kind of precious tea of ginseng five and preparation method thereof improving function of male | |
| CN101077178A (en) | Nutritive health-care food and its making method | |
| CN105961983A (en) | Solid beverage and preparation method thereof | |
| CN107811095A (en) | A kind of preparation method of the compound pressed candy of pomegranate jujube | |
| CN105124077A (en) | Passion fruit and tomato tea bag | |
| CN102972815A (en) | Onion health beverage and production method thereof | |
| CN106578286A (en) | Anti-alcohol fresh ginger and citrus peel fudge and preparation method thereof | |
| CN102972838A (en) | Chestnut flower health drink and preparation method thereof | |
| CN102150909A (en) | Selenium rich corn juice beverage composition and preparation method thereof | |
| CN107969695A (en) | A kind of spirulina tablet and preparation method thereof | |
| CN105325837A (en) | Blood fat-lowering spirulina flour and preparation method thereof | |
| CN104116070A (en) | Health-care selenium-rich organic green-tea health-preserving crispy cake and preparation method thereof | |
| CN111296598B (en) | Composite black jerusalem artichoke sports tea beverage and preparation method thereof | |
| CN106666377A (en) | Chenopodium quinoa willd and lophatherum gracile strengthened nutritive rice having various health-care functions and preparation method of chenopodium quinoa willd and lophatherum gracile strengthened nutritive rice | |
| CN106265833A (en) | A kind of Flos Lonicerae effervescent tablet and preparation method thereof | |
| CN104839791B (en) | One kind is delivered vegetables health care buccal tablets preparation method | |
| CN104938730A (en) | Passion fruit sweet tea | |
| CN103535575A (en) | Novel formula and production technology of rose pollen tablet product |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180501 |
|
| RJ01 | Rejection of invention patent application after publication |